About the Cover
Cover image

In patients with inflammatory breast cancer, 18F-FDG PET/CT has been found to have good predictive value for pathologic response to neoadjuvant chemotherapy and outcome. See page 1315.
In patients with inflammatory breast cancer, 18F-FDG PET/CT has been found to have good predictive value for pathologic response to neoadjuvant chemotherapy and outcome. See page 1315.